Journal of Addictive Behaviors and Therapy Open Access

  • Journal h-index: 4
  • Journal CiteScore: 0.52
  • Journal Impact Factor: 0.28
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +32 25889658

Dr. Mohammed Akbar

Dr. Mohammed Akbar
Editor-in-Chief
Laboratory of Membrane Biochemistry and Biophysics, National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH); Email: akbarm@mail.nih.gov
USA

Biography

Dr. Mohammed Akbar received his Ph.D. from Gunma University, School of Medicine, Maebashi, Japan, where he investigated the signal transduction mechanisms of purinergic receptors under the supervision of Prof. Yoichi Kondo. For the past 18 years at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH), he has been conducting research on the effects of fatty acids and alcohol and their cell signaling mechanisms in neuronal cells and in animals. He also worked with opioids and their signaling mechanisms in addiction. His research interests are neuronal signaling, omega-3 fatty acids, alcohol and drug addiction mechanisms, liver diseases, oxidative stress, natural products and dietary supplements in metabolic syndromes and neurodegenerative diseases. He has published more than 30 papers in peer-reviewed journals, co-authored 2 books, and given 13 invited presentations in different countries, including USA, Japan, Austria, Oman, and South Korea. He is currently serving as a reviewer for the journals; Nutritional Neuroscience; The Journal of Nutrition, Health and Aging; International Journal of Nutrition, Pharmacology and Neurological Disease; Physiology and Behavior; Oxidative Stress and Cellular Longevity.

Research Interest

Neuronal signaling, omega-3 fatty acids, alcohol and drug addiction mechanisms, liver diseases, oxidative stress, natural products and dietary supplements in metabolic syndromes and neurodegenerative diseases